Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05907343
Other study ID # STUDY00003055
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 31, 2023
Est. completion date December 31, 2026

Study information

Verified date June 2023
Source University of Texas at Austin
Contact José del R. Millán, PhD
Phone 512-232-8111
Email jose.millan@austin.utexas.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: - whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and - whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of sham, closed-loop, and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 31, 2026
Est. primary completion date December 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Cognitively normal younger adults 1. Ages between 18 to 35 years 2. Good general health 3. Normal or corrected vision 4. Completed elementary school education or able to understand middle school level experiment instructions - Cognitively normal older adults 1. Ages between 60 to 90 years 2. Good general health 3. Normal or corrected vision 4. Completed elementary school education or able to understand middle school level experiment instructions 5. Score of 23 or higher on the Montreal Cognitive Assessment, a brief formal cognitive screening test, which is used to indicate absence of cognitive impairment - Older adults with mild cognitive impairment (MCI) 1. Ages between 60 to 90 years 2. Diagnosis of MCI according to the National Institute on Aging - Alzheimer's Association (NIA-AA) criteria 3. Good general health 4. Normal or corrected vision 5. Completed elementary school education or able to understand middle school level experiment instructions Exclusion Criteria: 1. Neurological or psychiatric diseases (e.g., personal history of epilepsy/seizure brain damage, multiple sclerosis, schizophrenia, substance use disorder, etc.). 2. Current use of psychotropic medications with cognitive side effects (e.g., benzodiazepines, anticonvulsants, antipsychotics, etc.) 3. Current use of cognitive enhancing medications (e.g., Adderall, Memantine, etc.) 4. Factors hindering EEG acquisition and TMS delivery (e.g., skin infection, wounds, dermatitis, etc.) 5. Factors hindering MRI acquisition (e.g., implants, metallic tattoos, etc.)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sham TBS
A BCI records and analyzes the participant's EEG as they perform cognitively demanding video game tasks. The BCI delivers TBS with a sham coil when its output indicates that the participant is not properly engaged in the video game.
Closed-loop TBS
A BCI records and analyzes the participant's EEG as they perform cognitively demanding video game tasks. The BCI delivers TBS with a real coil when its output indicates that the participant is not properly engaged in the video game.
Open-loop TBS
A BCI records and analyzes the participant's EEG as they perform cognitively demanding video game tasks. TBS with the real coil is delivered irrelevant of the BCI decoder output.

Locations

Country Name City State
United States Health Discovery Building Austin Texas

Sponsors (1)

Lead Sponsor Collaborator
University of Texas at Austin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Behavioral performance of the video game task The behavioral performance, pressing or not pressing a button, reflects the level of cognitive control performance of the subjects. It measures whether the participants made a correct decision, and their response time, in a given trial. Up to 1 hour after intervention
Primary Accuracy of the BCI classifier output The BCI classifier output reflects the presence or absence of the cognitive EEG patterns elicited during the cognitive videogame tasks. For each participant, the BCI outputs will be compared to their behavioral responses (pressing or not pressing a button). Up to 1 hour after intervention
Primary Cognitive assessment I: Montreal Cognitive Assessment Telephone version, Score range: 0 - 22* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment II: Hopkins Adult Reading Test Score range: 70 - 131* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment III: Multilingual Naming Test Score range: 0 - 32* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment IV: Animal Naming Score range: 0 - 40* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment V: Number Span Forward, Score range: 0 - 14* (Units on a Scale)
Backward, Score range: 0 - 14* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment VI: Trail Making Test Parts A and B, Score range: 10 - 300** (Units on a Scale)
(** high scores = worse)
Up to 8 weeks after intervention
Primary Cognitive assessment VII: Southwestern Assessment of Processing Speed Score range: 0 - 75* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment VIII: Hopkins Verbal Learning Test-Revised Immediate Total, Score range: 0 - 36* (Units on a Scale)
Delayed Recall, Score range:0 - 12* (Units on a Scale)
Percent Retention, Score range:0 - 100* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment IX: Brief Visuospatial Memory Test-Revised Immediate Total, Score range: 0 - 36* (Units on a Scale)
Delayed Recall, Score range:0 - 12* (Units on a Scale)
Percent Retention, Score range:0 - 100* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment X: Controlled Oral Word Association Test Score range: 0 - 80* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
Primary Cognitive assessment XI: Stroop Color and Word Test Word, Score range: 0 - 140* (Units on a Scale)
Color, Score range:0 - 120* (Units on a Scale)
Color-Word, Score range:0 - 80* (Units on a Scale)
(* high scores = better)
Up to 8 weeks after intervention
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A